Nektar Therapeutics
NKTR
#4684
Rank
NZ$3.43 B
Marketcap
NZ$119.59
Share price
-3.25%
Change (1 day)
469.95%
Change (1 year)

Nektar Therapeutics (NKTR) - Cash on Hand

Cash on Hand as of December 2025 : NZ$0.42 Billion

According to Nektar Therapeutics 's latest financial reports the company has NZ$0.42 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Nektar Therapeutics - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31NZ$0.42 B-6.24%
2024-12-31NZ$0.45 B-5.74%
2023-12-31NZ$0.48 B-39.64%
2022-12-31NZ$0.79 B-25.98%
2021-12-31NZ$1.07 B-26.99%
2020-12-31NZ$1.47 B-25.19%
2019-12-31NZ$1.96 B-1.18%
2018-12-31NZ$1.99 B377.44%
2017-12-31NZ$0.41 B-25.77%
2016-12-31NZ$0.56 B24.44%
2015-12-31NZ$0.45 B48.71%
2014-12-31NZ$0.30 B5.23%
2013-12-31NZ$0.28 B-14.4%
2012-12-31NZ$0.33 B9.04%
2011-12-31NZ$0.30 B-24.54%
2010-12-31NZ$0.40 B-24.93%
2009-12-31NZ$0.54 B-16.47%
2008-12-31NZ$0.65 B3.71%
2007-12-31NZ$0.62 B-3.27%
2006-12-31NZ$0.65 B-6.56%
2005-12-31NZ$0.69 B18.72%
2004-12-31NZ$0.58 B33.4%
2003-12-31NZ$0.43 B-21.68%
2002-12-31NZ$0.56 B-32.27%
2001-12-31NZ$0.82 B-24.2%
2000-12-31NZ$1.09 B313.77%
1999-12-31NZ$0.26 B68.17%
1998-12-31NZ$0.15 B-8.92%
1997-12-31NZ$0.17 B555.69%
1996-12-31NZ$26.32 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
NZ$35.01 B 8,079.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$23.68 B 5,432.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.90 B 3,614.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$3.42 B 699.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$25.36 B 5,826.71%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$9.96 B 2,227.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
NZ$57.71 M-86.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$1.02 B 139.35%๐Ÿ‡ฎ๐Ÿ‡ช Ireland